Flanders, known as Pharma Valley, ranks first globally in the number of drugs in clinical developmen t per capita. Especially biotechnological drug development is gaining a lot of importance herein . Consequentially, t he demand for advanced analytical workflows to characterize the production of biological drugs and assess pharmacokinetics has significantly increased. Current analytical methods involve costly instrumentation and expertise, encouraging the use of service based workflows. With our new MS core facility, launched in early 2023, we aim to serve the pharmaceutical sector and improve sample through put by automating sample preparation and reducing runtime using high flow LC. In collaboration with a biotherapeutics company focused on nanobodies, new methodologies will be developed to track the pharmacokinetics of biological substances in animals, enha ncing biotherapeutic research. As a second application, the Laboratory of Toxicology will utilize the expanded version of the Andrew+ to automate the analysis of the alcohol withdrawal marker Phosphatidylethanol (PEth).